Enediyne Chimeras for Targeted NAMPT Degradation: Enhancing Cytotoxicity via a Radical Clock

Area of Science:

• Medicinal Chemistry
• Oncology
• Biochemistry

Background:

• Nicotinamide phosphoribosyltransferase (NAMPT) is an oncogenic protein implicated in cancer progression.
• Targeted protein degradation offers a promising strategy for cancer therapy by eliminating key oncogenic proteins.

Purpose of the Study:

• To design and synthesize novel chimeric enediyne compounds using the Protein-Radical-Oxidation Targeting Enediyne Chimera (PROTEC) platform.
• To evaluate the efficacy of these compounds in targeting NAMPT and inducing cytotoxicity in cancer cells.

Main Methods:

• Synthesis of a series of enediyne compounds with varying linker lengths and cyclopropane modifications.
• Computational studies including docking to assess protein-ligand interactions.
• In vitro cytotoxicity assays using human ovarian cancer A2780 cells.

Main Results:

• The incorporation of a cyclopropane group enhanced the "radical clock" mechanism, improving hydrogen abstraction.
• PROTEC-4 exhibited strong binding affinity to NAMPT, confirmed by docking studies.
• PROTEC-4 demonstrated significant cytotoxicity against A2780 cells with an IC50 of 0.24 μM.

Conclusions:

• The novel PROTEC platform successfully generated potent NAMPT-targeting compounds.
• PROTEC-4 shows considerable potential as an antitumor agent for ovarian cancer.
• Further development of PROTEC-based therapeutics is warranted for cancer treatment.